A new challenge for Cur-OST presented itself this week. We have an 11 y.o TBX admitted to our hospital for rehab purposes. The story behind this guy is that he sustained damage to the right rear suspensory ligament, lateral branch, about 1 year ago. He has been through many different types of treatment, including shock wave therapy, with minimal results. He is also on several supplements each day with a dose of phenylbutazone usually on an every other day basis to control pain. He is fairly sound at the walk, but the lameness quickly becomes evident at a light trot. He has obvious enlargement and thickening of the ligament just above the fetlock joint. Our goal is to improve this guy's quality of life, decrease the pain and improve motion. Future competition is not a priority, but more so we just want to make his life more comfortable and reduce his need for phenylbutazone due to potential long term health consequences. Our initial therapy included removal of his current shoes, allowing him to go barefoot and re-establish normal balance in his feet. We also started him on Cur-OST Green twice daily for 14 days as a starter. As a side therapy, we are also performing cold laser therapy to the suspensory region on a twice weekly basis.
Today is actually day 8 of therapy. We have performed 3 laser treatments, removed the shoes and continued the Cur-OST Green. He is currently off of bute for the past 4 days as well as his other supplements. He is doing very well, feels comfortable and moving freely when turned out in a small area. To be honest, we were anticipating a very painful horse once the shoes were removed due to his conformation and under-run heels. No problems encountered post shoe removal. So far so good...keeping our chins up but realizing we are still very early in the recovery process. We have used our Cur-OST Green formula with acute tendon issues with good success, but this type of injury will be a first and a new challenge for our product.
Case updates to follow....stay tuned.
Tom Schell, D.V.M.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment